CorMedix
CRMD
5 hedge funds and large institutions have $1.52M invested in CorMedix in 2013 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
35% more capital invested
Capital invested by funds: $1.13M → $1.52M (+$391K)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.2% less ownership
Funds ownership: 1.72% → 1.52% (-0.2%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$231 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.95K |
| 2 |
U
UBS
Zurich,
Switzerland
|
-$3.54K |
CRMD Hedge Fund Activity: Q4 2013 in Review
5 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q4 2013, worth a combined $1.52M — up 35% from $1.13M a quarter earlier.
Fund positioning in CRMD was balanced in Q4 2013: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 2 trimmed.
The largest buyer was Bank of America, opening a new position worth an estimated $231. The largest seller was Deutsche Bank, cutting an estimated $3.95K.
- 5 institutional investors held CorMedix (CRMD) as of Q4 2013, unchanged from Q3 2013.
- Funds reported $1.52M of CorMedix stock for Q4 2013, up 35% quarter-over-quarter.
- 1 fund opened new CorMedix positions in Q4 2013 and 1 closed out, a net change of 0 holders.
- The largest CorMedix buyer in Q4 2013 was Bank of America, an estimated $231 added.
- The largest CorMedix seller in Q4 2013 was Deutsche Bank, an estimated $3.95K sold.
Based on aggregated 13F filings for Q4 2013.